These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26468333)

  • 1. High glucose induces and activates Toll-like receptor 4 in endothelial cells of diabetic retinopathy.
    Wang L; Wang J; Fang J; Zhou H; Liu X; Su SB
    Diabetol Metab Syndr; 2015; 7():89. PubMed ID: 26468333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paeoniflorin Suppressed High Glucose-Induced Retinal Microglia MMP-9 Expression and Inflammatory Response via Inhibition of TLR4/NF-κB Pathway Through Upregulation of SOCS3 in Diabetic Retinopathy.
    Zhu SH; Liu BQ; Hao MJ; Fan YX; Qian C; Teng P; Zhou XW; Hu L; Liu WT; Yuan ZL; Li QP
    Inflammation; 2017 Oct; 40(5):1475-1486. PubMed ID: 28639050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4.
    Du M; Martin A; Hays F; Johnson J; Farjo RA; Farjo KM
    Mol Vis; 2017; 23():185-197. PubMed ID: 28400700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of TLR4 alleviates the inflammation and apoptosis of retinal ganglion cells in high glucose.
    Hu L; Yang H; Ai M; Jiang S
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2199-2210. PubMed ID: 28808786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
    Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
    Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx.
    Pahwa R; Nallasamy P; Jialal I
    J Diabetes Complications; 2016; 30(4):563-72. PubMed ID: 26908090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4 in bone marrow-derived cells contributes to the progression of diabetic retinopathy.
    Wang H; Shi H; Zhang J; Wang G; Zhang J; Jiang F; Xiao Q
    Mediators Inflamm; 2014; 2014():858763. PubMed ID: 25214718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-146a Attenuates Inflammatory Pathways Mediated by TLR4/NF-κB and TNFα to Protect Primary Human Retinal Microvascular Endothelial Cells Grown in High Glucose.
    Ye EA; Steinle JJ
    Mediators Inflamm; 2016; 2016():3958453. PubMed ID: 26997759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of toll-like receptor 4 ameliorates diabetic retinopathy in mice.
    Fu H; Liu H
    Arch Physiol Biochem; 2023 Apr; 129(2):519-525. PubMed ID: 33156707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
    Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
    Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Inflammatory Activity of Adenosine 5'-Trisphosphate in Lipopolysaccharide-Stimulated Human Umbilical Vein Endothelial Cells Through Negative Regulation of Toll-Like Receptor MyD88 Signaling.
    Luo X; Xiao B; Xiao Z
    DNA Cell Biol; 2019 Dec; 38(12):1557-1563. PubMed ID: 31580158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Andrographolide ameliorates diabetic retinopathy by inhibiting retinal angiogenesis and inflammation.
    Yu Z; Lu B; Sheng Y; Zhou L; Ji L; Wang Z
    Biochim Biophys Acta; 2015 Apr; 1850(4):824-31. PubMed ID: 25641276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B; Sun JH; Xiang FF; Liu L; Li WJ
    Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy.
    Kanda A; Dong Y; Noda K; Saito W; Ishida S
    Sci Rep; 2017 Nov; 7(1):16168. PubMed ID: 29170525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR7 deficiency contributes to attenuated diabetic retinopathy via inhibition of inflammatory response.
    Liao YR; Li ZJ; Zeng P; Lan YQ
    Biochem Biophys Res Commun; 2017 Nov; 493(2):1136-1142. PubMed ID: 28843858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epac1 Blocks NLRP3 Inflammasome to Reduce IL-1
    Jiang Y; Liu L; Curtiss E; Steinle JJ
    Mediators Inflamm; 2017; 2017():2860956. PubMed ID: 28348460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes derived from platelet-rich plasma mediate hyperglycemia-induced retinal endothelial injury via targeting the TLR4 signaling pathway.
    Zhang W; Dong X; Wang T; Kong Y
    Exp Eye Res; 2019 Dec; 189():107813. PubMed ID: 31560926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats.
    Carrillo-Sepulveda MA; Spitler K; Pandey D; Berkowitz DE; Matsumoto T
    J Mol Med (Berl); 2015 Dec; 93(12):1341-54. PubMed ID: 26184970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excess glucose induce trophoblast inflammation and limit cell migration through HMGB1 activation of Toll-Like receptor 4.
    Heim KR; Mulla MJ; Potter JA; Han CS; Guller S; Abrahams VM
    Am J Reprod Immunol; 2018 Nov; 80(5):e13044. PubMed ID: 30175447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peroxisome proliferator-activated receptor pan-agonist bezafibrate suppresses microvascular inflammatory responses of retinal endothelial cells and vascular endothelial growth factor production in retinal pigmented epithelial cells.
    Usui-Ouchi A; Ouchi Y; Ebihara N
    Int Immunopharmacol; 2017 Nov; 52():70-76. PubMed ID: 28866026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.